Not all stem cell treatments produce the same results.
Through our proprietary EvoSTEM technology, we maximize stem cell survival rates and differentiation potential.
By combining NK cell therapy with personalized treatment protocols, we achieve scientifically proven and clinically superior outcomes.
The key lies in cell quality, activation technology, and clinical expertise.
We don't simply inject stem cells; we enhance stem cell function before administration and apply precise personalized protocols based on years of accumulated clinical experience.
NK cells directly attack tumor cells, while stem cells help repair tissues damaged by chemotherapy or radiation therapy.
This dual approach with NK cells and stem cells strengthens immunity, improves treatment response, and enhances the quality of life for cancer patients.
For dementia patients, MMSE cognitive scores improved by 30% to 100% within one month, and for Parkinson's disease patients, motor symptoms improved by more than 60% within three months.
Stem cells regenerate damaged brain nerve cells and tissues, while NK cells eliminate cancer cells and inflammatory cells, creating an optimal environment for healing.
These two cell types create a synergistic effect of regeneration and immune enhancement.
It varies depending on the patient's condition, but generally, effects last from 6 months to over 5 years.
The duration can be further extended with additional treatments.
We primarily use the patient's own stem cells and NK cells, so there is no immune rejection reaction.
You may experience mild fever or temporary fatigue initially, but this is a natural phenomenon as the cells settle in and fight existing inflammation or viruses.
